![Gordon Cameron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gordon Cameron
Finanzdirektor/CFO bei
Quotient Sciences Ltd.
Vermögen: 95 366 $ am 31.07.2026
Profil
Gordon Cameron currently works at Quotient Sciences Ltd., as Chief Financial Officer & Director from 2007, Quotient Sciences (Reading) Ltd., as Chief Financial Officer & Director from 2013, and Quad UK Topco Ltd., as Secretary & Director.
Mr. Cameron also formerly worked at Acambis Plc, as Chief Executive Officer and Quotient Bioscience Ltd., as Chief Financial Officer.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Baronsmead Second Venture Trust Plc
 Baronsmead Second Venture Trust Plc Investment Trusts/Mutual FundsMiscellaneous Functions as an open-end investment fund 0,02 % | 01.11.2025 | 89 000 ( 0,02 % ) | 57 012 $ | 31.07.2026 |
Gresham House Income & Growth VCT Plc
 Gresham House Income & Growth VCT Plc Investment ManagersFinance Functions as a private equity fund 0,01 % | 01.10.2025 | 50 000 ( 0,01 % ) | 38 354 $ | 31.07.2026 |
Aktive Positionen von Gordon Cameron
| Unternehmen | Position | Beginn |
|---|---|---|
Quotient Sciences Ltd.
 Quotient Sciences Ltd. Pharmaceuticals: MajorHealth Technology Engages in contract research and contract manufacturing of stages of small molecule and synthetic peptide drugs | Finanzdirektor/CFO | 01.01.2007 |
Quotient Sciences (Reading) Ltd.
 Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Develops preclinical and early phase formulations and manufactures clinical trials materials | Finanzdirektor/CFO | 01.01.2013 |
Quad UK Topco Ltd.
 Quad UK Topco Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries engages in research, development and manufacturing of pharmaceutical activities | Direktor/Vorstandsmitglied | 01.10.2019 |
Ehemalige bekannte Positionen von Gordon Cameron
| Unternehmen | Position | Ende |
|---|---|---|
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines | Präsident | 09.03.2007 |
Quotient Bioscience Ltd.
 Quotient Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Offers drug development services | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines | Health Technology |
Quotient Bioscience Ltd.
Quotient Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Offers drug development services | Commercial Services |
Quotient Sciences Ltd.
Quotient Sciences Ltd. Pharmaceuticals: MajorHealth Technology Engages in contract research and contract manufacturing of stages of small molecule and synthetic peptide drugs | Health Technology |
Quotient Sciences (Reading) Ltd.
Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Develops preclinical and early phase formulations and manufactures clinical trials materials | Health Technology |
Quad UK Topco Ltd.
Quad UK Topco Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries engages in research, development and manufacturing of pharmaceutical activities | Health Technology |
